Home/ Stocks/ LGND

Ligand Pharmaceuticals Inc.

LGND XNAS

$221.41 +11.08 (+5.27%) ▲ 15-min delayed

Open

$212.20

High

$223.78

Low

$206.02

Volume

250.0K

Market Cap

$4.44B

About Ligand Pharmaceuticals Inc.

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 47 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$268.09M	$124.45M	$6.44
FY 2025	$268.09M	$124.45M	$6.44
Q3 2025	$115.46M	$117.27M	$5.99
Q2 2025	$47.63M	$4.85M	$0.25

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026

Calendar →

Related Market News

No specific coverage for LGND yet. Check out our latest market news or earnings calendar.

Get LGND Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Ligand Pharmaceuticals Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.